# Vasopressor Requirements Depends on Sedation Strategy

> **NCT05451381** · NA · COMPLETED · sponsor: **Anesthesia Research Group UA** · enrollment: 356 (actual)

## Conditions studied

- Sedative Adverse Reaction
- Sedation Complication
- Hemodynamic Instability
- Agitation on Recovery From Sedation
- Respiratory Complication

## Interventions

- **DRUG:** Propofol
- **DRUG:** Dexmedetomidine
- **DRUG:** Dexmedetomidine and Propofol

## Key facts

- **NCT ID:** NCT05451381
- **Lead sponsor:** Anesthesia Research Group UA
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-08-01
- **Primary completion:** 2022-05-01
- **Final completion:** 2022-05-29
- **Target enrollment:** 356 (ACTUAL)
- **Last updated:** 2022-07-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05451381

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05451381, "Vasopressor Requirements Depends on Sedation Strategy". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT05451381. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*